The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: a1-antitrypsin, Quantitative, A1AT, Quantitative, AAT, Quantitative, Alpha1 Antitrypsin, Quantitative, Alpha1Antitrypsin Quantitative
Also known as: AFP and AFP-L3%, AlphaFetoprotein AFP and AFPL3
Also known as: Bilirubin Fractionated
Also known as: Copper Oxide, Wilson's Disease
Also known as: Chem 12, Chemistry Panel, Chemistry Screen, CMP, Complete Metabolic Panel, Comprehensive Metabolic Panel CMP, SMA 12, SMA 20
Also known as: Gamma Glutamyl Transferase GGT, Gamma-Glutamyl Transferase, Gamma-Glutamyl Transpeptidase, Gamma-GT, GGTP, GTP
Also known as: Iron and TIBC, Iron and Total Iron Binding Capacity TIBC, TIBC
Also known as: Lactate Dehydrogenase LD, LDH
Also known as: Pro Time with INR, Prothrombin Time and International Normalized Ratio, Prothrombin Time PT with INR, Prothrombin Time with INR, Protime with INR, PT
The LH-2. Liver Health panel contains 9 tests with 35 biomarkers.
Brief Description: The LH-2 Liver Health panel is a comprehensive suite of tests designed to evaluate liver function, identify liver damage, and screen for specific liver disorders. This panel includes Quantitative Alpha-1-Antitrypsin, Alpha-Fetoprotein and AFP-L3, Fractionated Bilirubin (Direct, Indirect, and Total), Ceruloplasmin, Comprehensive Metabolic Panel, Gamma Glutamyl Transferase, Iron and Total Iron Binding Capacity, Lactate Dehydrogenase, and Prothrombin Time with INR. Each of these tests offers valuable insights into liver health, potential liver disease, and the liver's capacity to perform its vital functions.
Collection Method: Blood draw
Specimen Type: Whole Blood and Serum
Test Preparation: Patient should be fasting for at least 9 hours prior to collection. Specimen collection should be done in the morning.
Healthcare providers may order the LH-2 panel for individuals showing symptoms of liver disease, such as jaundice, abdominal pain, nausea, or fatigue. It's also recommended for patients with a history of liver disease, those exposed to liver-damaging substances, or individuals with a family history of liver disorders. This panel aids in diagnosing liver conditions, monitoring the progression of existing liver disease, and evaluating the effectiveness of treatment.
This panel can aid in diagnosing and managing several liver-related conditions:
Healthcare professionals utilize LH-2 panel results to:
For a more in-depth liver health assessment, consider the LH-3 and LH-4 Liver Health panels:
The LH-2 Liver Health panel offers a broad perspective on liver health, enabling the detection, monitoring, and management of liver diseases. It serves as a critical tool for healthcare providers in diagnosing liver conditions, assessing liver function, and guiding treatment decisions. For patients and physicians seeking an even more comprehensive liver health assessment, the LH-3 and LH-4 panels provide additional markers and tests to cover a wider spectrum of liver health concerns.
We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.